The extent to which leptin protects against obesity is unknown. By intercrossing New Zealand obese mice with lean C57BLa6J mice, we have separated the genes controlling leptin and other weight-related phenotypes. This has allowed us to determine whether hyperleptinaemia is associated with reduced food intake and increased physical activity in mice spanning a large range in body weight. METHODS: Plasma leptin, glucose and insulin, body weight, food intake, running wheel activity, and four adipose depots were measured in 587 adult F2 and backcross mice RESULTS: When mice were categorized by adiposity, a plot of food intake vs leptin illustrated a U-shaped curve. Food intake decreased as leptin levels rose to $15 ngaml, beyond which the relationship reversed. A negative relationship was observed between activity and leptin with a maximal decrease in activity once leptin reached $15 ngaml. CONCLUSION: Leptin has differential responses to food intake and activity, suggesting that it has limited potential to defend against obesity. A genetic defect in leptin sensitivity is unlikely to be the primary cause of obesity in these mice, since hyperleptinaemia was not coinherited with both hyperphagia and inactivity as body weight increased.
Introduction
The discovery of leptin and its receptor ®nally showed the existence of a long-suspected feedback mechanism between adipose tissue and the brain that has the capacity to regulate body weight. 1 ± 3 In theory, leptin should protect against obesity because a rise in body fat will increase circulating leptin, which should decrease food intake and increase energy expenditure. This theory is supported by the fact that leptin can induce weight loss in a dose-dependent manner in lean mice when given as a chronic infusion at leptin levels within the physiological range. 4 Leptin may therefore provide some resistance against excessive weight gain, but the extent to which leptin is capable of this is not known. It is possible that leptin protects against excess body weight only once body fat (and leptin levels) reach a critical threshold value and this regulation may have an upper limit over and above which leptin insensitivity develops. The fact that most obese human subjects have excessive amounts of circulating leptin that do not appear to be functioning properly has raised the possibility that human obesity is characterized by leptin insensitivity. 5 Although this has not been conclusively demonstrated, two studies have shown that the ef®ciency of leptin uptake into the brain is lower in obese human subjects, 6 ,7 providing a potential mechanism for leptin insensitivity in humans. In addition, central and peripheral leptin administration studies in rodents have shown that leptin insensitivity is a feature of many different hyperleptinaemic animal models of obesity, including the New Zealand obese (NZO) mouse, diet-induced obese mice, A y mice and OLETF rats. 4,8 ± 10 For example, a 14-day subcutaneous 500 ngah leptin infusion produces a 15% reduction in total body weight and a complete loss of body fat in lean C57BLa6J mice, but has no effect on body weight in NZO mice. 4 Therefore leptin insensitivity is a common feature of rodent obesity and appears to be a feature of human obesity despite the diverse range of factors causing the obesity, making it possible that leptin insensitivity develops as a consequence of obesity and perhaps as a consequence of hyperleptinaemia.
Alternatively, leptin may play a relatively minor role in protecting against overnutrition and there may be other weight-regulating circulating hormones yet to be discovered that are more important than leptin in regulating excess body weight. It seems likely that these exist because some unknown factor or factors must be responsible for the wasting and ultimate death of lean mice when parabiosed to hyperleptinaemic dbadb mice, 11 since large, chronic doses of leptin (500 ngah intracerebroventricular (i.c.v.) for 2 weeks) produce no more than a 20% decrease in body mass. 4 Some of these weight-regulating factors may be secreted by brown adipose tissue, since altering metabolism in this tissue can have a have a major impact on satiety independent of leptin. 12, 13 It is dif®cult to determine which effects of leptin are primary and which may be caused by other factors. One way of addressing this issue is to separate genes controlling phenotypes, and determine which related trails are coinherited. The NZO mouse is an interesting, polygenic model of severe obesity and noninsulin dependent diabetes, showing hyperleptinaemia and leptin insensitivity. 4, 8 As an adult, it is very inactive but not hyperphagic. 14 In these respects, it differs from most other mouse strains, including the lean strain C57BLa6J. The aim of this study was to examine the relationship between plasma leptin, food intake and physical activity in over 500 adult mice derived from obese NZO Â lean C57BLa6J genetic crosses to observe whether leptin levels are genetically separable from other phenotypes, and whether increased leptin is associated with reduced food intake andaor increased physical activity in mice spanning a large range in body weight.
Methods

Mice
The obese NZO mouse was originally established in New Zealand in 1948 by selectively inbreeding mice for an agouti coat colour. A colony of these mice has been maintained by the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, since the 1960s. As part of an ongoing study to identify the genes causing obesity in the NZO mouse, we bred these NZO mice with lean C57BLa6J mice (obtained from the Jackson Laboratory, Bar Harbor, Maine via the WEHI) to produce an F1 generation that was used in three genetic crosses. Two backcrosses were produced either by crossing F1 males with NZO females (maternal backcross or mBC) or by crossing F1 females with NZO males (paternal backcross or pBC), and F1 males were mated with F1 females to produce F2 generation mice. A total of 587 mice were generated: 26 female and 15 male mBC mice, 92 female and 78 male pBC mice, and 181 female and 195 male F2 mice. After weaning, all mice were maintained on commercial mouse breeder chow containing 9% of energy as fat.
Metabolic characteristics
At 36 weeks of age, mice were fasted overnight and a blood sample taken through the retroorbital sinus. Blood samples were collected into heparinized tubes, placed on ice and centrifuged to prepare plasma. Fasting plasma glucose was determined using a glucose oxidase method (YSI 2300 glucose analyser, Yellow Springs, OH, USA). After the blood sample was taken, mice were individually housed for 7 days in rat boxes containing a 15 cm diameter running wheel and had ad libitum access to chow. Voluntary physical activity levels were measured by continuous monitoring of the use of the running wheels using a computerized meter. 15 Running wheel activity has been shown to correlate well with infrared photoelectric measurements of spontaneous motor activity. 16 An average of the values recorded over 24 h periods for days 4 ± 6 was used for analysis. For each mouse, the day-to-day coef®cient of variation in activity measurements was $34%. Food intake over 24 h for days 4 ± 6 was also measured and averaged. For each mouse, day-to-day coef®cient of variation in food intake measures was 23%. On day 7, mice were fasted for 12 h then anaesthetized with pentobarbitone sodium (Nembutal, Boehringer Ingelheim, n.s.W) administered by intraperitoneal injection (60 mgakg body weight). Body weight and body length were recorded before an intraperitoneal injection of glucose (IPGTT, 2 mgag body weight) was given. Twenty minutes after the glucose dose, mice were decapitated and trunk blood was collected into sequestrene tubes. Plasma from these samples was analysed for glucose, insulin and leptin. Insulin was determined by radioimmunoassay using a second antibody to separate free from bound fractions (interassay coef®cient of variation for this assay is 16% at 10 mUaL; Pharmacia, Uppsala, Sweden). Leptin was analysed using a mouse leptin radioimmunoassay kit the interassay coef®cient of variation for this assay is 3% at 5 ngaml; Linco, MO, USA). Four adipose tissue depots were excised and weighed, including interscapular brown adipose tissue (BAT), subcutaneous inguinal while adipose tissue (WAT), and two abdominal WAT depots Ð gonadal (either periovarian fat in female mice or epididymal fat in male mice) and infrarenal fat. Single depots of WAT were collected from the lefthand side of the animal. Infrarenal WAT lay dorsal to the kidneys next to the abdominal wall in a wellde®ned depot and did not include the fat surrounding the kidneys. Although the interscapular BAT depots could be clearly distinguished from surrounding subcutaneous WAT, some in®ltration of BAT by WAT is likely so BAT weights may not be as precise as the weights of the other adipose tissues measured in this study. For comparison, a group of 36-week-old NZO mice (®ve female, eight male) and 18 C57BLa6J mice (nine female, nine male) were studied using the same protocol.
Statistical analysis
Comparisons between more than two groups of mice were made using univariate ANOVA with a general linear model followed by the Tukey HSD test (SPSS for Windows 8.0). Single comparisons were made using Student's two-tailed t-test. Curve ®tting and regression analyses were performed using Cricket Graph III (Computer Associates International Inc., NY, USA).
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The study protocol was approved by the Royal Melbourne Hospital's Animal Ethics Committee.
Results
Body weight and adiposity
Within each genetic cross there was a large variation in body weight. Figure 1 illustrates this for the pBC and F2 populations. The Anderson ± Darling test showed a normal distribution pattern in all populations except the female F2 mice. As expected, the distribution patterns were shifted to the left in females compared to males and in F2 compared to BC populations. For females, the mean AE s.e.m. weight was 35.7AE 0.8 g for mBC, 34.8AE 0.4 g for pBC, and 31.4AE 0.4 g for F2, while for males the mean weight was 48.0 AE 1.6 g for mBC, 48.8AE 0.7 g for pBC and 42.6AE 0.4 g for F2 mice. Mean body weights were not signi®cantly different between mBC and pBC within each sex. Female weights varied over a smaller range than male weights (approximately 20 ± 45 g for females vs 25 ± 65 g for males). For comparison, Table 1 shows body weight measured in the pure NZO and C57BLa6J strains. Obese NZO mice were approximately twice the weight of lean C57BLa6J mice. They were also 12 ± 15% longer. When data from all the crossbred and pure strain mice were pooled, a positive correlation was found between body weight and body length (r 0.79, P`0.001), although above a body weight of 50 g there was little further increment in body length (data not shown).
Body weight correlated positively with adipose tissue depot weight. This correlation was linear for abdominal infrarenal WAT (r 0.86, P`0.001, Figure 2A ) and abdominal gonadal WAT (r 0.82 for females and r 0.84 for males; both P`0.001, data not shown). In contrast, the relationship was curvilinear for subcutaneous WAT (r 0.87) and BAT (r 0.72, both P`0.001, Figure 2B and C). These curvilinear relationships were observed for both female and male mice; however for the same body weight female mice had more subcutaneous and more BAT than male mice. For example, 100 female mice weighing 36.2AE 0.2 g had 32% more subcutaneous WAT (P`0.0001) and 15% more BAT (P`0.001) than 82 male mice weighing the same amount (36.2 AE 0.3 g; 0.332AE 0.012 vs 0.252AE 0.012 g of subcutaneous WAT and 0.075AE 0.002 vs 0.064AE 0.003 g of BAT in female and male mice, respectively). In contrast, abdominal infrarenal WAT was similar in male and female mice of equal body weight (0.161AE 0.006 vs 0.152AE 0.010 g, P n.s.).
Plasma leptin
As expected, there were signi®cant positive correlations between circulating plasma leptin concentrations and the weights of the different adipose tissue depots in the mice. For abdominal WAT the relationship was curvilinear (data not shown); however, for subcutaneous WAT the correlation was linear ( Figure 3) . As adiposity increased, the relationship between leptin and body fat weakened, indicated by the scatter in the Figure 1 Distribution of body weights in the paternal backcross (pBC) and F2 populations.
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Food intake and activity levels
When female mice were categorized into groups based on their abdominal infrarenal fat mass, food intake progressively fell as leptin rose until a mean fat mass of 0.220 g was reached ( Figure 4C ). At this point, fat mass was 6.5 times greater than the leanest group and body weight was 43% higher (38.8AE 0.6 vs 27.2 AE 0.4 g, P`0.0001), yet food intake had dropped by 35% (P`0.0001). However, as fat mass increased further, food intake increased. Food intakes in the male mice displayed the same trends as the female mice, in that there was a 26% reduction in food intake (P`0.01) as the abdominal fat pad weight increased 4.3-fold to a mean value of 0.322 g and body weight increased by 28% (47.9 AE 1.0 vs 37.3 AE 0.9 g, P`0.0001). However, as fat mass increased further, food intake increased so that food intake in the fattest male mice was not signi®cantly different from food intake in the leanest mice. Maintenance of adiposity in these adult male and female mice was therefore not related to hyperphagia, although the lack of suppression of food intake contributed to adiposity in the fattest group of male and female mice. However, adiposity was related to reduced physical activity. Figure 4D shows a progressive decrease in running wheel activity as abdominal adiposity increased in both the female and male mice. The fattest female mice did 45% less activity on a running wheel than the leanest female mice (P`0.02), while the fattest male mice did 48% less activity than the leaner male mice (P`0.05).
Food intake and activity data in Figure 4 are plotted as a function of plasma leptin in Figure 5 . Figure 5A illustrates a U-shaped curve for food intake and leptin such that food intake decreases as leptin rises to a value of $15 ngaml. Beyond this point this relationship changes and food intake appears to increase as leptin values rise further. A negative relationship between activity and plasma leptin is seen in Figure  5B with a maximal decrease in activity after leptin values reach $15 ngaml.
Plasma glucose and insulin
There were positive relationships between body weight and fasting plasma glucose (r 0.282, P`0.001) and body weight and IPGTT plasma insulin values (r 0.364, P`0.001) and a negative relationship between body weight and the IPGTT plasma glucose:insulin ratio (an estimate of insulin sensitivity), con®rming the well-known observation that increased body weight is associated with fasting hyperglycaemia and reduced insulin sensitivity. However, there were no signi®cant correlations between plasma glucose, insulin or the glucose:insulin ratio and either food intake or activity levels (data not shown). Although signi®cant obesity was observed in these mice and in the parent NZO strain, frank diabetes was not found in any mouse. Figure 4 Infrarenal white adipose tissue (WAT) weights of all mice ranked and categorized into incremental groups (shown on the x-axis). Mean ( AE s.e.m.) infrarenal WAT weights for female mice (white columns) and male mice (black columns) within these groups were the same and are illustrated in (A). Plasma leptin, food intake and physical activity within groups of female and male mice matched for adiposity are shown in (B) ± (D), respectively.
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Discussion
It is not yet clear whether physiological levels of leptin serve as a defence against excess body weight. By interbreeding a severely obese mouse with a lean strain we have generated a cohort of mice with a large range in body weight and circulating leptin concentrations. This has allowed us to observe whether the relationships between both leptin and food intake, and leptin and activity change as leptin concentrations rise. We have shown that food intake progressively falls in both female and male mice as plasma leptin rises to $15 ngaml. Beyond this leptin value, the negative relationship disappears. We need to be cautious in interpreting this correlation because of the dif®culty in distinguishing what is cause and what is effect, and because we do not know what other factors in¯uence circulating leptin levels and food intake in our mice. However, if we assume that leptin is the primary modulator of food intake in our mice and that absence of this modulation is evidence of leptin insensitivity, it would appear that food intake remains leptin sensitive up to a certain leptin level with subsequent development of leptin insensitivity. There has been only one longitudinal study which has examined the progressive loss of leptin sensitivity on food intake in mice as they develop obesity. In this study, leptin insensitivity was not present in AKR mice after 16 days of high-fat feeding despite a 25% increase in body weight, but after 50 days on the diet, once body weight had increased by 40%, leptin insensitivity was evident. 9 This ®ts with our data in which apparent leptin resistance appeared in mice having adiposity above a critical level. It is possible that leptin itself induces this leptin resistance. The ®nding that lethal yellow obese mice revert from leptin resistance to sensitivity when mated with hypoleptinaemic obaob mice demonstrates that reversing hyperleptinaemia can restore leptin sensitivity. 17 Studies showing that leptin binding within the choroid plexus of leptin-de®cient obaob mice is elevated, whereas leptin binding in the hyperleptinaemic dbadb mouse is reduced 18 also suggest that prolonged leptin exposure is capable of inducing leptin insensitivity. This may be mediated by SOCS-3, a suppressor of cytokine signalling, since this protein is rapidly and dramatically induced by leptin and can block leptininduced signal transduction. 19 It is not known why the parental NZO mice are insensitive to leptin. 4 The function of the NZO variant of the leptin receptor is apparently normal 8, 20 and NZO mice appear to respond normally to intracerebroventricular leptin but not to peripheral leptin, 4 which makes it likely that the defect lies in the transport of leptin across the blood ± brain barrier.
Although food intake appeared to be partly sensitive to leptin, crossbred mice continued to put on weight. This must have been at least partly due to a reduction in physical activity energy expenditure because resting energy expenditure would be higher not lower in these mice because of their increased mass, and reduced diet-induced thermogenesis (which accounts for only $10% of total energy expenditure) could not counteract a 26 ± 35% decrease in caloric intake. Therefore, a negative relationship is likely to exist between body weight and physical activity energy expenditure in our mice. It should be noted that this relationship would not be identical to the negative relationship we observed between adiposity and running wheel activity, since the amount of energy required to rotate the wheel would have increased to some extent as body mass increased. The negative correlation we found between leptin and physical activity is dif®cult to interpret given the uncertainly about whether leptin is capable of stimulating physical activity. Early studies showed 2 71088x 15597, r 0.96, P`0.001 for females and y 11.63x 2 7553x 9620, r 0.86, P`0.001 for males.
Leptin and obesity-related traits AW Thorburn et al that chronic doses of i.p. leptin (10 mgakgaday for 3 weeks) increased physical activity levels in leptinde®cient obese obaob mice. 21 However, most studies in human subjects have found no relationship between leptin and physical activity levels, 22, 23 with only one study in children showing a positive relationship. 24 The apparent inability of leptin to in¯uence physical activity in adult human subjects is also illustrated in a recent study that has shown that the activation of spontaneous physical activity in subjects who are resistant to weight gain after overfeeding is not mediated by leptin. 25 There is also some discrepancy in the literature as to whether circulating leptin concentrations in¯uence other components of energy expenditure such as resting energy expenditure. Again, most studies report negative relationships, 22,26 ± 28 although some positive relationships have been documented 29 in human subjects. The most convincing evidence that leptin does not have a major effect on resting energy expenditure and physical activity comes from a recently published study looking at the effect of leptin therapy in a child with congenital leptin de®ciency. This study showed that leptin administration had a dramatic effect on the patient's food intake but did not alter total energy expenditure. 30 It is therefore likely that leptin regulates body fat in humans predominantly by altering eating behaviour rather than by altering components of energy expenditure.
As our mice became more obese, their physical activity levels fell to a level 45 ± 48% below normal. Fatter mice may engage in less activity simply because they ®nd it harder to move around, but it is possible that reduced activity is responsible for causing the obesity. This is supported by our observation that reduced activity is an early defect in the NZO mouse; at only 8 weeks of age, activity is reduced by 72% in female NZO mice compared with lean C57BLa6J mice (5789 vs 20 452 cyclesaday, unpublished observations). Inactivity can also be an early defect in human obesity since reduced energy expenditure, particularly reduced physical activity, has been shown to be an important factor in the rapid weight gain during the ®rst year of life in infants born to overweight mothers. 31 In humans, there is some evidence that spontaneous physical activity is a familial trait that shows marked interindividual differences in its contribution to daily energy expenditure. 32 ± 34 In other species, genes have been shown to play a signi®cant role in controlling the level of physical activity. In fruit¯ies, for example, mutations in a larval foraging gene have been shown to affect adult locomotor behaviour after feeding 35 and, in animals, several papers have been published showing that genes determine susceptibility to drug-induced locomotor activity changes. 36 Together this data suggests that inactivity may be an early, genetically determined defect predisposing to weight gain.
It is interesting that food intake begins to rise as the fall in activity begins to plateau, as if the requirement for positive energy balance is met by food intake once physical activity can decrease no further.
Excess abdominal and subcutaneous body fat in adult NZO mice is well documented. 37 At only 4 weeks of age, abnormal body composition in the NZO mouse is already evident with 52% of the dry weight of the animal composed of lipid compared with only 26% in a lean control animal. 14 We have further characterized the excess adiposity in this mouse model by showing that abdominal fat stores increase in direct proportion to body weight, whereas subcutaneous fat and brown fat appear to ®ll more slowly initially. Female mice deposit this subcutaneous and brown adipose tissue more ef®ciently than male mice of the same body weight. This is probably associated with the female's need for extra energy stores to call upon if food becomes scarce during pregnancy.
It is also worth noting the similar distribution of body weights in the two backcross populations produced by mating F1 mice with either female NZO mice or male NZO mice. Maternal hyperglycaemia during pregnancy has been proposed as a cause of obesity in the offspring in later life. 38 If this is so, it might be expected that the progeny from the maternal backcross would be heavier than the progeny from the paternal backcross, since progeny from the maternal backcross are likely to have been exposed to blood glucose levels 22% higher than normal in utero. 14 However, the mean and median weights for the maternal and paternal backcross populations were the same. Therefore our data do not support the hypothesis that intrauterine hyperglycaemia can lead to obesity. Studies which have tested this hypothesis by inducing hyperglycaemia in the pregnant mother by a continuous infusion of glucose in the last week of pregnancy 39 or by streptozotocin injection on day 1 of gestation 40 have also concluded that intrauterine hyperglycaamia does not cause persistent obesity in the offspring.
The NZO mouse has been studied well because it is a good model of human obesity. We found that patterns of adiposity and leptin secretion in the crossbred mice used in this study are very similar to those reported in humans in that subcutaneous adiposity is greater in females than males of the same body weight, leptin secretion in females per gram of adipose tissue is greater than males, and increasing adiposity is associated with increased leptin concentrations. The paradox of increasing obesity in the face of decreasing food intake may be explained by decreased activity levels in our adult mice. Decreased activity has also been blamed for the increasing prevalence of clinical obesity in Britain over the past 20 y in the presence of a decline in total energy intake. 41 This further reinforces the suitability of this animal model in the study of human obesity. It should be emphasized that this study was conducted in 36-week-old mice. Different responses to leptin may have been seen had younger mice in rapid weight¯ux been studied.
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In conclusion, increasing leptin concentrations correlated with decreased food intake to some extent in adult mice. Despite this lower food intake, body weight continued to increase, most likely due to a decrease in physical activity energy expenditure. This data suggests that leptin does not serve as an effective defence against excess body weight across a range of stable body weights. The fact that hyperleptinaemia did not consistently correlate with both hyperphagia and inactivity as body weight increased suggests that a genetic defect in leptin sensitivity is unlikely to be the primary cause of obesity in the NZO mouse.
